These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36637147)

  • 1. Randomized double-blind placebo-controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and use of corticosteroids in children and adolescents with atopic dermatitis.
    Feíto-Rodríguez M; Ramírez-Boscà A; Vidal-Asensi S; Fernández-Nieto D; Ros-Cervera G; Alonso-Usero V; Prieto-Merino D; Núñez-Delegido E; Ruzafa-Costas B; Sánchez-Pellicer P; Genovés S; Navarro-López V
    Clin Exp Dermatol; 2023 Apr; 48(5):495-503. PubMed ID: 36637147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial.
    Gerasimov SV; Vasjuta VV; Myhovych OO; Bondarchuk LI
    Am J Clin Dermatol; 2010; 11(5):351-61. PubMed ID: 20642296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial.
    Navarro-López V; Ramírez-Boscá A; Ramón-Vidal D; Ruzafa-Costas B; Genovés-Martínez S; Chenoll-Cuadros E; Carrión-Gutiérrez M; Horga de la Parte J; Prieto-Merino D; Codoñer-Cortés FM
    JAMA Dermatol; 2018 Jan; 154(1):37-43. PubMed ID: 29117309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study.
    Wu YJ; Wu WF; Hung CW; Ku MS; Liao PF; Sun HL; Lu KH; Sheu JN; Lue KH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):684-692. PubMed ID: 26733351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS).
    Torrelo A; Rewerska B; Galimberti M; Paller A; Yang CY; Prakash A; Zhu D; Pontes Filho MAG; Wu WS; Eichenfield LF
    Br J Dermatol; 2023 Jul; 189(1):23-32. PubMed ID: 36999560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness of Probiotic
    Cukrowska B; Ceregra A; Maciorkowska E; Surowska B; Zegadło-Mylik MA; Konopka E; Trojanowska I; Zakrzewska M; Bierła JB; Zakrzewski M; Kanarek E; Motyl I
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome.
    Woo SI; Kim JY; Lee YJ; Kim NS; Hahn YS
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):343-8. PubMed ID: 20408346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months.
    Diepgen TL;
    Pediatr Allergy Immunol; 2002 Aug; 13(4):278-86. PubMed ID: 12390444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).
    Simpson EL; Gooderham M; Wollenberg A; Weidinger S; Armstrong A; Soung J; Ferrucci S; Lima RG; Witte MM; Xu W; ElMaraghy H; Natalie CR; Pierce E; Blauvelt A;
    JAMA Dermatol; 2023 Feb; 159(2):182-191. PubMed ID: 36630140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure.
    Wang IJ; Wang JY
    Clin Exp Allergy; 2015 Apr; 45(4):779-87. PubMed ID: 25600169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
    Silverberg JI; Adam DN; Zirwas M; Kalia S; Gutermuth J; Pinter A; Pink AE; Chiricozzi A; Barbarot S; Mark T; Tindberg AM; Weidinger S
    Am J Clin Dermatol; 2022 Jul; 23(4):547-559. PubMed ID: 35857179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
    Paller AS; Simpson EL; Siegfried EC; Cork MJ; Wollenberg A; Arkwright PD; Soong W; Gonzalez ME; Schneider LC; Sidbury R; Lockshin B; Meltzer S; Wang Z; Mannent LP; Amin N; Sun Y; Laws E; Akinlade B; Dillon M; Kosloski MP; Kamal MA; Dubost-Brama A; Patel N; Weinreich DM; Yancopoulos GD; O'Malley JT; Bansal A;
    Lancet; 2022 Sep; 400(10356):908-919. PubMed ID: 36116481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rice flour fermented with Lactobacillus paracasei CBA L74 in the treatment of atopic dermatitis in infants: A randomized, double- blind, placebo- controlled trial.
    D'Auria E; Panelli S; Lunardon L; Pajoro M; Paradiso L; Beretta S; Loretelli C; Tosi D; Perini M; Bedogni G; Abdelsalam A; Fiorina P; Bandi C; Zuccotti GV
    Pharmacol Res; 2021 Jan; 163():105284. PubMed ID: 33157233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
    Bieber T; Reich K; Paul C; Tsunemi Y; Augustin M; Lacour JP; Ghislain PD; Dutronc Y; Liao R; Yang FE; Brinker D; DeLozier AM; Meskimen E; Janes JM; Eyerich K;
    Br J Dermatol; 2022 Sep; 187(3):338-352. PubMed ID: 35484697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
    Chan S; Cornelius V; Cro S; Harper JI; Lack G
    JAMA Pediatr; 2020 Jan; 174(1):29-37. PubMed ID: 31764962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Oral Administration of a Heat-Treated Lactobacillus paracasei  Supplement in Infants with Atopic Dermatitis Receiving Topical Corticosteroid Therapy.
    Yan DC; Hung CH; Sy LB; Lue KH; Shih IH; Yang CY; Chen LC; Sun HL; Lee MS; Chambard J; Tanguy J; Hughes-Formella B; Nutten S; Blanchard C
    Skin Pharmacol Physiol; 2019; 32(4):201-211. PubMed ID: 31117100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis.
    Han Y; Kim B; Ban J; Lee J; Kim BJ; Choi BS; Hwang S; Ahn K; Kim J
    Pediatr Allergy Immunol; 2012 Nov; 23(7):667-73. PubMed ID: 23050557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.